Peter Nash
0000-0002-2571-788X
Griffith University
193 papers found
Refreshing results…
Comparative efficacy and safety of bimekizumab in psoriatic arthritis: a systematic literature review and network meta-analysis
MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
Systematic literature review and network meta-analysis of therapies for psoriatic arthritis on patient-reported outcomes
Comorbidities in RA: bringing them to the limelight
Impact of COVID-19 on Patients With Psoriasis or Psoriatic Arthritis
Proceedings of the GRAPPA 2022 Executive Retreat
Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies – Adult patients
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis
JAK inhibitors: new indication and emerging safety data in 2022
Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV Trial
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
Management of Axial Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update
Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms
Janus Kinase Inhibitors: Safety in Patients With Psoriatic Arthritis
Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritis
Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritis
Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials
The Effect of Etanercept in Nonradiographic Axial Spondyloarthritis by Stratified C‐Reactive Protein Levels
A comparison of Janus kinase inhibitor safety in rheumatoid arthritis
Missing publications? Search for publications with a matching author name.